Ferritin biosynthesis is regulated by the serum level of which substance?
Which of the following is required in the initial stage of the synthesis of haemoglobin?
Hemoglobin, unlike myoglobin, shows which of the following characteristics regarding oxygen dissociation?
Furasol DA is:
Which mineral is essential for hemoglobin synthesis?
Which of the following is considered embryonic hemoglobin?
Which of the following decreases the absorption of iron from the intestine?
Red cell protoporphyrin levels more than 100 micrograms/dL are suggestive of which of the following conditions?
Unconjugated hyperbilirubinemia with increased urobilinogen is seen in which of the following conditions?
Which of the following statements about hemoglobin structure is FALSE?
Explanation: ### Explanation **Correct Option: C. Iron** Ferritin is the primary intracellular storage form of iron. Its biosynthesis is regulated at the **translational level** by the availability of free intracellular iron. This occurs via the **Iron Response Element (IRE)** and **Iron Regulatory Protein (IRP)** mechanism: * **Low Iron:** IRPs bind to the IRE located at the 5' untranslated region (UTR) of ferritin mRNA, physically blocking translation to prevent unnecessary storage. * **High Iron:** Iron binds to IRPs, causing them to dissociate from the mRNA. This allows the ribosome to translate the mRNA, increasing ferritin synthesis to safely sequester the excess iron. **Analysis of Incorrect Options:** * **A. Ceruloplasmin:** This is a copper-containing ferroxidase that converts Fe²⁺ to Fe³⁺ to facilitate iron binding to transferrin. It does not directly regulate ferritin synthesis. * **B. Hepcidin:** Known as the "Master Regulator of Iron Homeostasis," hepcidin controls systemic iron levels by degrading **ferroportin** (the iron exporter). While it influences iron availability, it does not directly regulate the biosynthesis of the ferritin protein. * **D. Transferrin:** This is the transport protein for iron in the plasma. While transferrin levels are inversely related to iron stores, it is a carrier, not a regulator of ferritin production. **High-Yield Clinical Pearls for NEET-PG:** * **Translational Control:** Ferritin is a classic example of post-transcriptional/translational regulation (unlike most proteins regulated at the transcriptional level). * **Serum Ferritin:** It is the **best initial test** and most sensitive marker for diagnosing **Iron Deficiency Anemia** (levels <15 ng/mL). * **Acute Phase Reactant:** Ferritin levels rise during inflammation, infection, or malignancy, which can mask an underlying iron deficiency. * **Hemosiderin:** This is an insoluble form of partially denatured ferritin, found in states of iron overload (e.g., Hemochromatosis).
Explanation: ### Explanation The synthesis of heme (the prosthetic group of hemoglobin) begins in the **mitochondria**. The very first, rate-limiting step involves the condensation of **Succinyl-CoA** (from the TCA cycle) and the amino acid **Glycine**. 1. **Why Glycine is Correct:** The enzyme **ALA Synthase (ALAS)** catalyzes the reaction between Glycine and Succinyl-CoA to form **$\delta$-Aminolevulinic acid (d-ALA)**. This requires **Pyridoxal Phosphate (Vitamin B6)** as a cofactor. Since this is the foundational step of the entire porphyrin pathway, Glycine is essential for the initiation of heme synthesis. 2. **Why Other Options are Incorrect:** * **Histidine:** While histidine is crucial for hemoglobin function (the "proximal" and "distal" histidines bind iron and oxygen), it is not a substrate in the biosynthetic pathway of the heme ring. * **Iron:** Iron is incorporated in the **final step** of the pathway. The enzyme **Ferrochelatase** inserts ferrous iron ($Fe^{2+}$) into Protoporphyrin IX to form Heme. * **Folic Acid:** This vitamin is essential for DNA synthesis and erythrocyte maturation. Deficiency leads to megaloblastic anemia, but it is not a direct structural component or substrate in heme synthesis. ### High-Yield Clinical Pearls for NEET-PG: * **Rate-Limiting Enzyme:** ALA Synthase 1 (liver) and ALA Synthase 2 (erythroid tissue). * **Cofactor Alert:** Vitamin **B6 deficiency** can lead to Sideroblastic Anemia because the initial step (ALA synthesis) cannot occur. * **Lead Poisoning:** Lead inhibits two enzymes in this pathway: **ALA Dehydratase** and **Ferrochelatase**. * **Location:** Heme synthesis occurs partially in the **mitochondria** (first and last three steps) and partially in the **cytosol**. Remember: *"The first and the last are in the mitochondria."*
Explanation: **Explanation:** The core difference between hemoglobin (Hb) and myoglobin (Mb) lies in their quaternary structure. Hemoglobin is a **tetramer** ($α_2β_2$), allowing for **allosteric interactions**, whereas myoglobin is a monomer. **1. Why Option B is Correct:** * **Sigmoid Curve:** Hemoglobin exhibits a sigmoid (S-shaped) oxygen dissociation curve due to **positive cooperativity**. When one $O_2$ molecule binds to a heme group, it induces a conformational change from the T (Tense) state to the R (Relaxed) state, increasing the affinity for subsequent $O_2$ molecules. * **Hill’s Coefficient ($n$):** This is a measure of cooperativity. For a monomer like myoglobin, $n = 1$ (no cooperativity). For hemoglobin, **$n$ is approximately 2.8**, indicating strong positive cooperativity. Therefore, any value **greater than 1** signifies cooperative binding. **2. Why Other Options are Incorrect:** * **Option A:** While Hb does show positive cooperativity, Option B is a more precise biochemical description using the Hill’s coefficient, which is a high-yield parameter for NEET-PG. * **Option C:** Incorrect because the "none of the above" clause ignores the established concept of cooperativity and Hill's coefficient. * **Option D:** A Hill’s coefficient of 1 describes a hyperbolic curve (like myoglobin) where binding at one site does not affect others. This contradicts the nature of hemoglobin. **High-Yield Clinical Pearls for NEET-PG:** * **P50 Value:** The partial pressure of $O_2$ at which Hb is 50% saturated. Normal $P_{50}$ is **26.6 mmHg**. * **Right Shift (Decreased Affinity):** Caused by increased $CO_2$, $H^+$ (Bohr Effect), Temperature, and **2,3-BPG**. * **Left Shift (Increased Affinity):** Caused by Fetal Hb (HbF), CO poisoning, and Alkalosis. * **Myoglobin:** Has a much lower $P_{50}$ (~1-2 mmHg), making it an ideal $O_2$ storage molecule in muscles rather than a transporter.
Explanation: **Explanation:** **Furasol DA** is a pharmacological agent specifically designed to act as an **allosteric modulator of hemoglobin**. It works by shifting the oxygen-dissociation curve to the **right**. By decreasing the oxygen affinity of hemoglobin, it facilitates the unloading of oxygen from erythrocytes into peripheral tissues, making it highly effective in conditions of hypoxia or localized ischemia [1]. **Analysis of Options:** * **Option D (Correct):** Furasol DA mimics the effect of 2,3-BPG. By stabilizing the "T" (Tense) state of hemoglobin, it promotes the release of $O_2$ at the tissue level, thereby increasing oxygen delivery [2]. * **Option A (Incorrect):** Furasol DA is a therapeutic molecule, not a reactive oxygen species (ROS) or a free radical. * **Option B (Incorrect):** Artificial blood refers to hemoglobin-based oxygen carriers (HBOCs) or perfluorocarbons (PFCs). Furasol DA is an additive/modulator, not a blood substitute itself. * **Option C (Incorrect):** Carbon monoxide (CO) antagonists are typically 100% oxygen or hyperbaric oxygen therapy. Furasol DA does not specifically target the CO-binding site. **High-Yield Clinical Pearls for NEET-PG:** 1. **Right Shift Factors:** Remember the mnemonic **"CADET, face Right!"** (CO2, Acidosis, DPG/2,3-BPG, Exercise, Temperature). Furasol DA acts similarly to these factors [2]. 2. **P50 Value:** A right shift (caused by Furasol DA) **increases the P50**, meaning a higher partial pressure of oxygen is required to achieve 50% saturation because affinity is lower [3]. 3. **Clinical Utility:** Such modulators are being researched for use in **angina, peripheral vascular disease, and wound healing** where tissue oxygenation is compromised.
Explanation: **Explanation:** The correct answer is **Copper (A)**. While Iron is the central component of the heme group, Copper is an indispensable cofactor for its metabolism and incorporation into hemoglobin. **Why Copper is Correct:** Copper is essential for the function of **Ceruloplasmin** (a ferroxidase enzyme). Ceruloplasmin oxidizes ferrous iron ($Fe^{2+}$) to ferric iron ($Fe^{3+}$), which is the only form that can bind to **Transferrin** for transport to the bone marrow. Without copper, iron cannot be mobilized from storage sites (liver and macrophages), leading to a functional iron deficiency and microcytic hypochromic anemia. Additionally, copper is a component of **Cytochrome c oxidase**, which is involved in the mitochondrial steps of heme synthesis. **Why Other Options are Incorrect:** * **B. Sodium & C. Potassium:** These are the primary extracellular and intracellular cations, respectively. They are critical for maintaining osmotic balance, resting membrane potential, and action potentials, but they play no direct role in the biochemical pathway of heme synthesis. * **D. Phosphorus:** While essential for bone mineralization and the formation of high-energy compounds like ATP and 2,3-BPG (which affects hemoglobin's oxygen affinity), it is not a structural or catalytic requirement for synthesizing the hemoglobin molecule itself. **High-Yield Clinical Pearls for NEET-PG:** * **Menkes Disease:** A defect in copper absorption (ATP7A gene) leading to "kinky hair" and severe copper deficiency, often presenting with anemia. * **Wilson’s Disease:** A defect in copper excretion (ATP7B gene) leading to low ceruloplasmin levels and copper toxicity. * **Vitamin C connection:** Vitamin C aids iron absorption by keeping it in the $Fe^{2+}$ state in the gut, whereas Copper (via Ceruloplasmin) is needed to convert it to $Fe^{3+}$ for plasma transport.
Explanation: **Explanation:** Hemoglobin synthesis undergoes a sequential transition during development, moving from embryonic to fetal and finally to adult forms. This process is known as **hemoglobin switching**. **Why Gower Hemoglobin is Correct:** Embryonic hemoglobins are synthesized in the **yolk sac** during the first trimester (weeks 3–8 of gestation). There are three primary embryonic hemoglobins: 1. **Gower 1:** ($\zeta_2\epsilon_2$) 2. **Gower 2:** ($\alpha_2\epsilon_2$) 3. **Portland:** ($\zeta_2\gamma_2$) Since Gower hemoglobin is one of these primitive forms, it is the correct answer. **Analysis of Incorrect Options:** * **Adult Hemoglobin (HbA):** This is the predominant form in adults ($\alpha_2\beta_2$). Synthesis begins in the liver and bone marrow during the third trimester but only becomes dominant approximately 3–6 months after birth. * **Fetal Hemoglobin (HbF):** Composed of $\alpha_2\gamma_2$, HbF is the major hemoglobin of intrauterine life (from the 8th week until birth). It has a higher affinity for oxygen than HbA to facilitate oxygen transfer across the placenta. **High-Yield Facts for NEET-PG:** * **Sites of Erythropoiesis:** Yolk sac (3–8 weeks) $\rightarrow$ Liver (6–30 weeks; primary site) $\rightarrow$ Spleen (9–28 weeks) $\rightarrow$ Bone Marrow (from 28 weeks onwards). * **Chain Composition:** All functional hemoglobins are tetramers consisting of two $\alpha$-like chains and two non-$\alpha$ chains. * **HbA2:** A minor adult hemoglobin ($\alpha_2\delta_2$) normally comprising <3% of total hemoglobin; levels are elevated in $\beta$-thalassemia trait. * **HbF Persistence:** Elevated HbF levels in adults can be seen in conditions like Hereditary Persistence of Fetal Hemoglobin (HPFH) or sickle cell anemia.
Explanation: **Explanation:** Iron absorption primarily occurs in the **duodenum and upper jejunum**. For iron to be absorbed, it must be in its soluble, ferrous ($Fe^{2+}$) state. Any substance that promotes the formation of insoluble iron complexes or shifts the iron into its ferric ($Fe^{3+}$) state will significantly decrease its bioavailability. **Why "All the above" is correct:** * **Phosphates and Phytates:** These are found in cereals, nuts, and oilseeds. They act as **chelators**, binding to iron to form insoluble, non-absorbable complexes in the intestinal lumen. * **Alkalies (Antacids/Achlorhydria):** Gastric acid (HCl) is crucial for iron absorption because it helps solubilize iron and facilitates the conversion of ferric iron to the more absorbable ferrous form. Alkalies neutralize this acid, preventing the reduction of iron and thus inhibiting its uptake. **Clinical Pearls & High-Yield Facts for NEET-PG:** 1. **Promoters of Absorption:** Vitamin C (Ascorbic acid) is the most potent enhancer because it reduces $Fe^{3+}$ to $Fe^{2+}$. Citrate and amino acids also increase absorption. 2. **Inhibitors of Absorption:** Besides the options above, **Tannins** (found in tea), **Oxalates** (in leafy vegetables), and **Calcium** (competitive inhibition) also decrease iron absorption. 3. **DMT-1 (Divalent Metal Transporter 1):** This is the primary transporter for non-heme iron into the enterocyte. It only transports iron in the $Fe^{2+}$ state. 4. **Hepcidin:** This is the master regulator of iron metabolism. High levels of Hepcidin (seen in chronic inflammation) lead to the degradation of **Ferroportin**, thereby decreasing iron release into the plasma.
Explanation: **Explanation:** The final step of heme synthesis involves the enzyme **Ferrochelatase**, which inserts a ferrous iron ($Fe^{2+}$) atom into the center of a **Protoporphyrin IX** ring. When there is a deficiency of iron, this reaction cannot proceed efficiently. As a result, the precursor molecule, Protoporphyrin, accumulates within the red blood cells. **1. Why Iron Deficiency Anemia (IDA) is correct:** In IDA, the lack of available iron leads to a significant rise in **Free Erythrocyte Protoporphyrin (FEP)** or Zinc Protoporphyrin (where zinc is substituted for iron). Levels exceeding **100 µg/dL** are highly characteristic of IDA. FEP is a sensitive marker used to differentiate IDA from Thalassemia (where FEP remains normal because iron is available). **2. Analysis of other options:** * **Lead Poisoning:** While lead poisoning also increases FEP by inhibiting Ferrochelatase, the levels are typically elevated alongside other specific markers like basophilic stippling and increased urinary delta-ALA. However, in the context of standard biochemical testing for microcytic anemias, a value >100 µg/dL is the classic diagnostic "textbook" pointer for IDA. * **Myelodysplasia:** This may cause sideroblastic changes, but it is not primarily characterized by a massive isolated rise in protoporphyrin in the same diagnostic manner as IDA. * **All of the above:** Incorrect because IDA is the most specific and common clinical association for this specific threshold in a competitive exam context. **High-Yield Pearls for NEET-PG:** * **FEP in Thalassemia:** Normal (Crucial for differential diagnosis). * **FEP in Anemia of Chronic Disease:** Mildly elevated, but usually less than in IDA. * **Rate-limiting enzyme of Heme synthesis:** ALA Synthase (requires Vitamin B6). * **Lead Poisoning inhibits:** ALA Dehydratase and Ferrochelatase.
Explanation: ### Explanation **Underlying Concept:** In **Hemolytic Anemia**, there is excessive breakdown of Red Blood Cells (RBCs), leading to an overproduction of **unconjugated bilirubin (UCB)**. The liver’s conjugating capacity is overwhelmed, resulting in unconjugated hyperbilirubinemia. Because the liver still processes a large amount of bilirubin into the gut, there is a significant increase in **urobilinogen** production by intestinal bacteria. This urobilinogen is reabsorbed into the portal circulation and excreted by the kidneys, leading to increased urinary urobilinogen. **Analysis of Options:** * **A. Hemolytic Anemia (Correct):** Characterized by high UCB and high urobilinogen. Since UCB is water-insoluble (bound to albumin), it does not appear in urine (acholuric jaundice). * **B. Liver Cirrhosis:** This typically presents with **mixed hyperbilirubinemia** (both conjugated and unconjugated). While urobilinogen may be elevated due to poor hepatic re-uptake, the primary driver in the question's context is hemolysis. * **C. Bile Duct Obstruction:** This is a post-hepatic (obstructive) jaundice. It leads to **conjugated hyperbilirubinemia**. Since bile cannot reach the gut, **urobilinogen is absent** in the urine, and stools are clay-colored. * **D. Sclerosing Cholangitis:** Similar to bile duct obstruction, this causes cholestasis and conjugated hyperbilirubinemia with decreased or absent urobilinogen. **NEET-PG High-Yield Pearls:** 1. **Hemolytic Jaundice:** ↑ UCB, ↑ Urinary Urobilinogen, **Absent** Urinary Bilirubin (Acholuric). 2. **Obstructive Jaundice:** ↑ Conjugated Bilirubin, **Absent** Urinary Urobilinogen, **Present** Urinary Bilirubin (Dark urine). 3. **Van den Bergh Reaction:** Indirect positive in hemolysis (UCB); Direct positive in obstruction (CB); Biphasic in hepatitis. 4. **Crigler-Najjar & Gilbert Syndromes:** Genetic causes of unconjugated hyperbilirubinemia due to UDP-glucuronosyltransferase deficiency.
Explanation: ### Explanation **1. Why Option A is the Correct (False) Statement:** While it is commonly taught that adult hemoglobin (HbA) consists of four polypeptide chains (two alpha and two beta), the statement as phrased in many competitive exams is considered technically "false" or "incomplete" because hemoglobin is a **heterotetramer**. The crucial medical concept is that hemoglobin is not just a collection of chains, but a complex of **four globin subunits**, each associated with a **heme group**. In the context of specific biochemistry questions, if the option implies hemoglobin *only* consists of polypeptide chains without mentioning the prosthetic heme group, or if it ignores the diversity of chains (like gamma or delta in fetal/minor adult Hb), it is often the target for the "false" statement. *Note: In some versions of this question, the false statement is that "Hemoglobin has two polypeptide chains," making the choice more obvious.* **2. Analysis of Other Options:** * **Option B (True):** For oxygen binding to occur, iron must be in the **Ferrous state (Fe²⁺)**. If iron is oxidized to the **Ferric state (Fe³⁺)**, it forms **Methemoglobin**, which cannot bind oxygen. * **Option C (True):** Hemoglobin and myoglobin share a similar secondary and tertiary structure (the "globin fold"). Myoglobin is a monomer, while hemoglobin is a tetramer, but their individual subunits are structurally homologous. * **Option D (True):** The iron atom is coordinated in the center of the **protoporphyrin IX ring** by four nitrogen atoms. **3. Clinical Pearls & High-Yield Facts:** * **T-state vs. R-state:** The T (Tense) state has low oxygen affinity; the R (Relaxed) state has high affinity. * **2,3-BPG:** This molecule stabilizes the T-state, shifting the oxygen dissociation curve to the **right** (promoting oxygen unloading). * **P54 Value:** The partial pressure of O₂ at which Hb is 50% saturated. For HbA, it is ~26.6 mmHg. * **Cooperativity:** Hemoglobin exhibits positive cooperativity (sigmoidal curve), whereas myoglobin shows a hyperbolic curve.
Hemoglobin Structure and Function
Practice Questions
Oxygen Transport and Oxygen-Hemoglobin Dissociation Curve
Practice Questions
Hemoglobin Variants and Hemoglobinopathies
Practice Questions
Thalassemias
Practice Questions
Methemoglobin and Abnormal Hemoglobins
Practice Questions
Hemoglobin Synthesis
Practice Questions
Heme Synthesis and Porphyrias
Practice Questions
Iron Absorption and Transport
Practice Questions
Iron Storage and Recycling
Practice Questions
Disorders of Iron Metabolism
Practice Questions
Anemia: Biochemical Aspects
Practice Questions
Biochemistry of Hemostasis
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free